3rd Quarter - Amendment
340B HEALTH for 340B HEALTH
Firm
Client
Income
—
Expenses
$161,917
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 17, 2008 | $161,917 | Replaced |
| 3rd Quarter - Amendment (this page) | Aug 20, 2009 | $161,917 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
HR 2606 and S 1376. Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| STUART YAEL GORDON | — |
| ROBERT RECKLAUS | COS for Carolyn McCarthy 02-08 |
| TED SLAFSKY | Fellow for Sen. Dem Policy Comm. 1994 |
| JAIMIE VICKERY | LA for Reps Horn and Bigger 00-05 |
| WILLIAM VON OEHSEN | — |
| BONNIE WEINTRAUB | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.